Cessation of Samhitha Kandlakunta due her tenure completed as Independent Director at the close of Business hours on 23rd september, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Ltd has informed BSE that Ms. Samhitha Kandlakunta (DIN: 08891727) ceases to be an Independent Director of the company at the close of business hours on September 23, 2025. Her exit is due to the natural completion of her 5-year term as an independent director, not due to resignation or any governance concern. The disclosure was made under SEBI Listing Regulations, and the company is yet to announce a replacement on the board.
This is a routine, planned board change with no negative implication for shareholders. Investors should watch for the appointment of a new independent director to ensure the board continues to meet SEBI's composition requirements.